URETER UROTHELIAL CARCINOMA
Clinical trials for URETER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new URETER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for URETER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo shows promise for tough bladder cancer
Disease control OngoingThis early-phase study tested two immunotherapy drugs (durvalumab and tremelimumab) given before surgery to people with a serious type of bladder cancer that cannot be treated with standard chemotherapy. The main goal was to check safety and side effects. Researchers also looked …
Matched conditions: URETER UROTHELIAL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New drug cocktail shows promise for Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase study tests a combination of two or three drugs (cabozantinib, nivolumab, and sometimes ipilimumab) in people with advanced genitourinary cancers that have spread. The main goals are to find the safest doses and understand side effects. About 152 adults with vari…
Matched conditions: URETER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC